Please assess the completion status of the following clinical trial:

Trial Title: SARS-CoV-2 OTC At Home Test

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Individuals suspected of COVID-19 disease by a healthcare provider or individuals who have tested positive within the past 7 calendar days with a confirmed positive COVID-19 test~2. Individuals able to self-administer the investigational test either upon themselves or upon their child (under sixteen (16) years of age) as a parent or guardian~3. Individuals willing and able to provide informed consent or obtain consent from legal authorized representative (LAR)~Exclusion Criteria:~1. If symptomatic, individuals with self-declared symptoms greater than 7 days (plus/minus 1 day, if symptoms start not definite)~2. Unable to provide consent or obtain consent from a LAR~3. Unwilling or unable to collect all sample types~4. Enrolled in a study to evaluate an investigational drug~5. Eating/drinking/smoking 30 minutes prior to specimen collection~6. Prisoner or under incarceration~7. Have contraindications to the collection of nasal specimens from the nares/nostrils, such as but not limited to nasal ulcers or nasal surgery within 3 months prior to sample collection

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Study Groups (Type: EXPERIMENTAL): Positives: Symptomatic vs. Asymptomatic Negatives: Symptomatic vs. Asymptomatic~Each broken down by age groups:~2-14 years old 15-24 years old 25-64 years old 65+ years old

Based on this trial design, predict the completion outcome and termination type (if applicable).